Miguel Martin

Aurora Cannabis Reports Strong Q2 Growth Driven By International Medical Marijuana Sales
Aurora Cannabis CEO Takes On Dual Role: Here's What's Behind The Leadership Change
Aurora's CBD Lozenge Partnership: Here's Where To Find The New Product
Aurora Cannabis CEO Takes On Dual Role: Here's What's Behind The Leadership Change
Aurora's CBD Lozenge Partnership: Here's Where To Find The New Product
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
Aurora Cannabis Shares Jump On Q1 FY25 Earnings, Global Medical Marijuana Yields Record Revenue Of $343M

Miguel Martin Recent News

Weed Legalization In Germany Just Took Effect: Here's What You Need To Know
German legalization will one of the many hot topics at the Benzinga Cannabis Capital Conference in Florida on April 16-17.
Aurora Cannabis (ACB): Canaccord Genuity Analysts Say Now's The Time To Buy. Find Out Why
Aurora Cannabis gets upgraded to 'Buy' by Canaccord Genuity analysts, spotlighting strategic growth and the MedReleaf Australia acquisition."
EXCLUSIVE: Aurora Cannabis CEO Discusses Record Earnings And Strategic Global Expansion (VIDEO)
Aurora Cannabis CEO Miguel Martin discusses strategic growth, global expansion, and record earnings in exclusive Benzinga podcast interview.
Aurora Touts 41% YoY Increase In International Medical Cannabis Q3 Revenue, Expands In Australia Via New Acquisition
Canadian medical cannabis company Aurora Cannabis reported its financial and operational results for Q3 2024. Net revenue increased to CAD64.4m ($42m), up from CAD61.1m in the same quarter the previous year. Medical cannabis net revenue rose by 16% to CAD45.1m, representing 70% of Aurora's consolidated net revenue. Gross profit reached CAD19.8m, up from CAD3.7m in Q3 2022, with adjusted gross profit before fair value adjustments increasing to CAD32.4m from CAD28m. The company recorded a CAD25.5m net loss compared to CAD67.2m in the same quarter in the previous year. Adjusted EBITDA came in at CAD4.3m, up from CAD3m. Miguel Martin, CEO of Aurora, said the company's international medical net revenue had seen year-on-year growth of 41%.
Cannabis On The NASDAQ? No Problem: A Look At Aurora's Positive Cash Flow Strategy, Agrify's Equity Boost
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a major cannabis company, is sticking to its previous financial predictions.
Aurora Cannabis Reports Strong Q2 2024 Results With Record Positive Adjusted EBITDA
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial and operational results for the second quarter of fiscal year 2024, ending September 30, 2023, revealing a record positive adjusted EBITDA of CAD $3.4 million.
Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced Tuesday that it had successfully completed a confidential settlement ‎resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB:
Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
Two cannabis giants each closed their respective funding deals on Tuesday.
Canadian Cannabis Giant Takes Strategic Steps To Reduce Debt & Boost Financial Stability
Aurora Cannabis Inc.
Aurora Cannabis Takes Bold Step Towards Financial Recovery
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has repurchased an aggregate of roughly CA$12.3 million ($9 million) principal amount of its convertible senior notes in multiple transactions between August 16 and September 8, 2023.
Aurora Cannabis Releases Strong Q1 2024 Financial Results Highlighting Substantial Adjusted EBITDA Growth
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) reported its financial results for Q1 fiscal year 2024, ending on June 30, 2023.
Aurora Cannabis Sells Sun Facility To Bevo
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) announced that a wholly-owned subsidiary of the company has closed the sale of its Medicine Hat, Alberta facility (the "Aurora Sun facility&
Weed Giant Aurora Posts Gross Profit Collapse: With The Drop From $16M To $583.3K, Does 3 Months Shorter Fiscal Year Matter?
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) released its financial and operational results for the third quarter and fiscal year 2023 results. The company’s fiscal 2023 is comprised of three quarters ending March 31, 2023.
Aurora And MedReleaf Australia Launch IndiMed Tempo 26, Expanding Product Offerings For Medical Cannabis Patients
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB),and MedReleaf Australia launched IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme.
'Cannabis Is Not Dead' Says Aurora CEO From Helm Of Largest Global Medical Marijuana Company
Last month Canadian marijuana giant, Aurora Cannabis Inc.
Prince Harry Says Cannabis Helped Him Cope With Mental Health Struggles & Ayahuasca Was A 'Release'
“Marijuana is different, that actually really did help me,” Prince Harry told physician and author Dr. Gabor Maté on Saturday in a widely viewed live-stream interview about the importance of personal healing.
Aurora And MedReleaf Australia Launch New Medical Cannabis Brand - CraftPlant
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) and MedReleaf Australia launched CraftPlant, a new medical cannabis brand for patients in the Australian market.
Aurora Cannabis Reports 2Q Results, Global Medical Cannabis Revenues Up
Aurora Cannabis Inc.
Aurora Cannabis' Health Plans, Hemp Pesticides In MA, Digital MJ Cards In NM, Virginia Delta 8, Oregon Pardons
Aurora Cannabis Aims For Health Plans In Canada
Aurora Cannabis Q1 Revenue Decreases 2% Sequentially, Following Wholesale Distribution Disruptions
Aurora Cannabis Inc. (NASDAQ: AC) (TSX: ACB), a Canadian leader in the cannabis industry serving both the medical and consumer markets,
Aurora Cannabis Reports 2022 Q4 Earnings: Revenue Flat Sequentially At C$50.2M, CEO Optimistic
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a Canadian global company in the cannabis industry, serving both the medical and consumer markets; recently announced its financial and operational results for the fourth quarter a
Aurora Cannabis Acquires Controlling Interest In Greenhouse Tech Experts, Bevo Farms
Aurora Cannabis Inc.
Aurora Cannabis Announces More Layoffs, Here's Why
Aurora Cannabis Inc. (NASDAQ: ACB) continues to trim its workforce as it seeks to achieve profitability.
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved